RxDoctor Payments DataLook up a doctor →

Chris McClinton, MD

Radiation Oncology · Fayetteville, ARNPI 1144586280

Payments from drug & device makers

$3,916in general payments, 2019–2025

Across 201 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$479
  • AstraZeneca$254
  • Brainlab, Inc.$228
  • Merck$225
  • Johnson & Johnson$197
  • Regeneron Healthcare Solutions, Inc.$183
  • plus $2K from 51 others
$1,036in research payments, 2019–2025

Across 4 payments — averaging $259.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis Pharma AG$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,916 in reported general payments places this provider in the 90th percentile of 45 radiation oncology providers in Arkansas.

See all radiation oncology providers in Arkansas

Medicare billing

Part B allowed, 2024
$1,432,448
Medicare patients
551
Services billed
6,247

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Fayetteville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →